167 related articles for article (PubMed ID: 26870914)
1. Long-term outcome of insulin pump therapy: reduction of hypoglycaemia and impact on glycaemic control.
Quirós C; Giménez M; Ríos P; Careaga M; Roca D; Vidal M; Conget I
Diabet Med; 2016 Oct; 33(10):1422-6. PubMed ID: 26870914
[TBL] [Abstract][Full Text] [Related]
2. Impact of insulin pump therapy on key parameters of diabetes management and diabetes related emotional distress in the first 12 months.
Oldham V; Mumford B; Lee D; Jones J; Das G
Diabetes Res Clin Pract; 2020 Aug; 166():108281. PubMed ID: 32628980
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the effectiveness of long-term insulin pump therapy using a combined goal of HbA
Quirós C; Viñals C; Giménez M; Roca D; Conget I
Endocrinol Diabetes Nutr (Engl Ed); 2019 Nov; 66(9):534-539. PubMed ID: 31133475
[TBL] [Abstract][Full Text] [Related]
4. Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years.
Linkeschova R; Raoul M; Bott U; Berger M; Spraul M
Diabet Med; 2002 Sep; 19(9):746-51. PubMed ID: 12207811
[TBL] [Abstract][Full Text] [Related]
5. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ
Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
[TBL] [Abstract][Full Text] [Related]
6. Indications for insulin pump therapy in different age groups: an analysis of 1,567 children and adolescents.
Kapellen TM; Heidtmann B; Bachmann J; Ziegler R; Grabert M; Holl RW
Diabet Med; 2007 Aug; 24(8):836-42. PubMed ID: 17650157
[TBL] [Abstract][Full Text] [Related]
7. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
Sulli N; Shashaj B
Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
[TBL] [Abstract][Full Text] [Related]
8. Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland.
Jeyam A; Gibb FW; McKnight JA; Kennon B; O'Reilly JE; Caparrotta TM; Höhn A; McGurnaghan SJ; Blackbourn LAK; Hatam S; McCrimmon RJ; Leese G; Lindsay RS; Petrie J; Chalmers J; Philip S; Wild SH; Sattar N; McKeigue PM; Colhoun HM;
Diabetologia; 2021 Jun; 64(6):1320-1331. PubMed ID: 33686483
[TBL] [Abstract][Full Text] [Related]
9. A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone.
Thomas RM; Aldibbiat A; Griffin W; Cox MA; Leech NJ; Shaw JA
Diabet Med; 2007 Jul; 24(7):778-83. PubMed ID: 17535290
[TBL] [Abstract][Full Text] [Related]
10. Continuous Subcutaneous Insulin Infusion in Adult Type 1 Diabetes Mellitus Patients: Results from a Public Health System.
Moreno-Fernandez J; Gomez FJ; Pinés P; González J; López J; López LM; Blanco B; Roa C; Herranz S; Muñoz-Rodríguez JR
Diabetes Technol Ther; 2019 Aug; 21(8):440-447. PubMed ID: 31199682
[No Abstract] [Full Text] [Related]
11. Sustained metabolic control and low rates of severe hypoglycaemic episodes in preschool diabetic children treated with continuous subcutaneous insulin infusion.
Pańkowska E; Szypowska A; Lipka M; Skórka A
Acta Paediatr; 2007 Jun; 96(6):881-4. PubMed ID: 17537017
[TBL] [Abstract][Full Text] [Related]
12. Improvement of β-cell function after achievement of optimal glycaemic control via long-term continuous subcutaneous insulin infusion therapy in non-newly diagnosed type 2 diabetic patients with suboptimal glycaemic control.
Choi SB; Lee JH; Lee JH; Kim S; Han SD; Kim IH; Noh YH
Diabetes Metab Res Rev; 2013 Sep; 29(6):473-82. PubMed ID: 23592489
[TBL] [Abstract][Full Text] [Related]
13. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
[TBL] [Abstract][Full Text] [Related]
14. Benefits of continuous subcutaneous insulin infusion (CSII) therapy in preschool children.
Levy-Shraga Y; Lerner-Geva L; Modan-Moses D; Graph-Barel C; Mazor-Aronovitch K; Boyko V; Pinhas-Hamiel O
Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):225-9. PubMed ID: 23329580
[TBL] [Abstract][Full Text] [Related]
15. Influence of health locus of control and fear of hypoglycaemia on glycaemic control and treatment satisfaction in people with Type 1 diabetes on insulin pump therapy.
Indelicato L; Mariano V; Galasso S; Boscari F; Cipponeri E; Negri C; Frigo A; Avogaro A; Bonora E; Trombetta M; Bruttomesso D
Diabet Med; 2017 May; 34(5):691-697. PubMed ID: 28145047
[TBL] [Abstract][Full Text] [Related]
16. Continuous subcutaneous insulin infusion (CSII) therapy at Derby Teaching Hospitals: sustained benefits in glucose control.
Anyanwagu U; Olaoye H; Jennings P; Ashton-Cleary S; Sugunendran S; Hughes D; Idris I; Wilmot EG
Diabet Med; 2017 Aug; 34(8):1154-1157. PubMed ID: 28430381
[TBL] [Abstract][Full Text] [Related]
17. Comparison of different insulin pump makes under routine care conditions in adults with Type 1 diabetes.
Leelarathna L; Roberts SA; Hindle A; Markakis K; Alam T; Chapman A; Morris J; Urwin A; Jinadev P; Rutter MK
Diabet Med; 2017 Oct; 34(10):1372-1379. PubMed ID: 28636773
[TBL] [Abstract][Full Text] [Related]
18. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
Pickup JC; Sutton AJ
Diabet Med; 2008 Jul; 25(7):765-74. PubMed ID: 18644063
[TBL] [Abstract][Full Text] [Related]
19. Impact of insulin pump therapy on long-term glycemic control in a pediatric Spanish cohort.
Colino E; Martín-Frías M; Yelmo R; Álvarez MÁ; Roldán B; Barrio R
Diabetes Res Clin Pract; 2016 Mar; 113():69-76. PubMed ID: 26972965
[TBL] [Abstract][Full Text] [Related]
20. Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with Type 1 diabetes.
Beato-Víbora P; Yeoh E; Rogers H; Hopkins D; Amiel SA; Choudhary P
Diabet Med; 2015 Nov; 32(11):1453-9. PubMed ID: 26213236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
